Back to search results

PathAI

STEX25
Active dates:

May 1, 2018 - May 1, 2018
STEX25
View Feature
STEX25 Participation:
May 1, 2018 - October 31, 2021
Company information
Contact

120 Brookline Avenue, Floor 1
Boston, MA 02215
United States

http://www.pathai.com
Elevator Pitch

Elevator Pitch

PathAI is advancing medicine with intelligent pathology. PathAI's platform provides end-to-end, automated and data-driven pathology analysis, resulting in fast, accurate and standardized pathologic diagnoses.
Description

Description

The mission at PathAI is to transform, accelerate and improve cancer diagnosis and cancer care by integrating pathology machine learning / artificial intelligence (AI) with traditional pathology methods in both research and clinical labs. By leveraging recent advances in computational processing power and AI, the conventional methods of pathology are disrupted and improved, leading to meaningful improvements in medicine and patient outcomes.

PathAI's revolutionary approach provides the highest level of standardization, accuracy and precision in pathology available today, delivering solutions to researchers and empowering pathologists with decision support tools.
Technology Description

Technology Description

PathAI is dedicated to improving patient outcomes with reliable AI-Powered technology and meaningful collaboration with biopharma, laboratories, and clinicians -- aiming to provide patients with access to accurate diagnoses and effective treatments.